Venus Medtech Acquires U.S. Company InterValve to Create a Systematic TAVR Treatment and Strengthen Global Expansion

HANGZHOU, China, June 14, 2017 -- (Healthcare Sales & Marketing Network) -- Venus Medtech announced on June 13, 2017 that it has purchased U.S. Company InterValve, the supplier of balloon aortic valvuloplasty products, and that the relevant delivery proce... Devices, Interventional, Cardiology, Mergers & Acquisitions Venus Medtech, InterValve, valvuloplasty, aortic valve, transcatheter, TAVR
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news